Huayun Xin (Hainan) Investment Partnership (Limited Partnership) signed an equity transfer agreement to acquire 24.34% stake in Winsan (Chengdu) Medical Science and Technology Co., Ltd. (SHSE:600767) from Sichuan Lanrun Asset Management Co., Ltd. for CNY 600 million on April 9, 2021. The share transfer price is paid in three installments, and the specific payment arrangements are as to for the first transfer payment, Huayun Xin (Hainan) Investment Partnership (Limited Partnership) shall pay the first transfer payment totaling CNY 100 million to Sichuan Lanrun Asset Management within 5 working days after the signing of this agreement. For the second transfer payment, Huayun Xin (Hainan) Investment Partnership (Limited Partnership) shall pay the second transfer payment totaling CNY 200 million Sichuan Lanrun Asset Management’s bank account within 10 working days from the date when the Shanghai Stock Exchange issues a share transfer confirmation opinion on this transaction. For the third transfer payment, Huayun Xin (Hainan) Investment Partnership (Limited Partnership) shall pay the remaining transfer amount of CNY 300 million to Sichuan Lanrun Asset Management’s bank account within 20 working days from the date when all the underlying shares are delivered. As of the date when the target shares are released or the underlying shares complete the share delivery, Sichuan Lanrun Assets will transfer all the voting rights, nomination and proposal rights, participation rights, and supervisory suggestions corresponding to the 82,979,928 unrestricted shares of Yunsheng Medical held by it. The right to know, the right to know, and other rights except the right to earn income and the right to dispose of shares are irrevocably entrusted to Huayun Hexin. If the underlying shares have ex-rights or ex-dividends during the period from the signing of this agreement to the delivery date of the underlying shares (hereinafter referred to as the "transition period"), the share transfer price and the transfer amount shall be based on the Chinese norms. The regulations of the China Securities Regulatory Commission will be adjusted accordingly. After the completion of the share transfer, Sichuan Lanrun Assets no longer holds the company's shares, Huayun Hexin becomes the company's controlling shareholder, and the company's actual controller is changed to Weng Songlin.